Skip to main content

Carter Bankshares, Inc. (CARE) Stock Forecast

Data as of Aug 7, 2026

Financial Services · Current price $33.99 (-3.22%)

Consensus Target
$30.75
Upside
-10.3%
Analysts
4
Rating
Hold(2.75)

Price Target Range

Low $27.00Consensus $30.75High $34.50
▲ Current $33.99

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Hold
Strong Buy0
Buy0
Hold3
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

CARE vs Sector & Market

MetricCAREFinancial Services AvgLarge Cap Avg
Analyst Rating2.752.522.42
Analyst Count4818
Target Upside-10.3%+95.2%+17.2%
P/E Ratio6.89-4.7435.26

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$46M$47M$47M1
2026-12-31$48M$48M$49M1
2027-03-31$47M$48M$48M1
2027-06-30$49M$49M$50M1
2027-09-30$50M$51M$52M1
2027-12-31$51M$52M$52M1
2028-12-31$179M$180M$181M1
2029-12-31$162M$163M$163M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$0.57$0.60$0.622
2026-12-31$0.61$0.62$0.631
2027-03-31$0.58$0.58$0.591
2027-06-30$0.60$0.61$0.621
2027-09-30$0.65$0.66$0.671
2027-12-31$0.65$0.66$0.671
2028-12-31$2.59$2.61$2.631
2029-12-31$3.07$3.09$3.111

Frequently Asked Questions

What is the analyst consensus for CARE?

The consensus among 4 analysts covering Carter Bankshares, Inc. (CARE) is Hold with an average price target of $30.75.

What is the highest price target for CARE?

The highest analyst price target for CARE is $34.50.

What is the lowest price target for CARE?

The lowest analyst price target for CARE is $27.00.

How many analysts cover CARE?

4 analysts have issued ratings for Carter Bankshares, Inc. in the past 12 months.

Is CARE a buy or sell right now?

Based on 4 analyst ratings, CARE has a consensus rating of Hold (2.75/5) with a -10.3% upside to the consensus target of $30.75.

What are the earnings estimates for CARE?

Analysts estimate CARE will report EPS of $0.60 for the period ending 2026-09-30, with revenue estimated at $47M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.